Dow Down0.68% Nasdaq Down0.42%

Oncolytics Biotech Inc. (ONCY)

-NasdaqCM
0.61 Down 0.09(12.59%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development17,417  31,538  22,968  
Selling General and Administrative5,075  5,308  5,239  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (22,493) (36,846) (28,206)
Income from Continuing Operations
Total Other Income/Expenses Net350  346  (278)
Earnings Before Interest And Taxes(22,143)(36,500)(28,485)
Interest Expense -   -   -  
Income Before Tax(22,143)(36,500)(28,485)
Income Tax Expense5  31  39  
Minority Interest -   -   -  
Net Income From Continuing Ops(22,148)(36,531)(28,524)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (22,148) (36,531) (28,524)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (22,148) (36,531) (28,524)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.